An Update on Oral Anti-coagulants

Antidotes for patients taking novel oral anti-coagulants.

Advances in Oral Coagulants

This article reviews current and future treatment practices concerning oral anticoagulants. In the second decade of the 21st millennium clinicians can finally treat thrombotic disease with long-awaited new oral anticoagulant medications. In addition, improvements have been made in managing warfarin, the traditional but far from obsolete medication. The first part of this review will cover curre...

an update on plant derived anti-androgens

anti-androgens are an assorted group of drugs and compounds that reduce the levels or activity of androgen hormones within the human body. disease states in which this is relevant include polycystic ovarian syndrome, hirsutism, acne, benign prostatic hyperplasia, and endocrine related cancers such as carcinoma of the prostate. we provide an overview and discussion of the use of anti-androgen me...

An Update on Plant Derived Anti-Androgens

Anti-androgens are an assorted group of drugs and compounds that reduce the levels or activity of androgen hormones within the human body. Disease states in which this is relevant include polycystic ovarian syndrome, hirsutism, acne, benign prostatic hyperplasia, and endocrine related cancers such as carcinoma of the prostate. We provide an overview and discussion of the use of anti-androgen me...

The Role of Novel Oral Anti-Coagulants in Stroke Prevention in Non-Valvualr Atrial Fibrillation

Atrial Fibrillation (AF) is the most common dysrhythmia seen in primary care. Thromboembolic stroke remains one of the most feared complications of this rhythm disturbance. Five landmark trials have demonstrated the efficacy of warfarin and aspirin in reducing this risk. Warfarin use is known to be labor intensive for patients and concerns regarding multiple drug interactions and bleed risk hav...